Long-Term Outcomes of Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Eculizumab in a Real-World Setting.

Katharina VersmoldFerras AlashkarCarina RaiserRichard Ofori-AsensoTao XuYutong LiuPablo KatzAijing ShangAlexander Röth

Published in: European journal of haematology (2023)

A considerable proportion of patients with PNH receiving eculizumab did not achieve optimal clinical outcomes and had an ongoing disease burden. This article is protected by copyright. All rights reserved.

Keyphrases

atrial fibrillation
blood pressure
obstructive sleep apnea
sleep quality
sleep apnea
risk factors
physical activity
depressive symptoms